Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
19 February 2021 - 8:15AM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that management will be participating in
the following investor conferences:
- Cowen 41st Annual Health Care Conference Date: Monday,
March 1st at 2:40 p.m. Eastern Time
- H.C. Wainwright Global Life Sciences Conference Date:
Tuesday, March 9th at 7:00 a.m. Eastern Time
- Barclays Global Healthcare Conference Date: Wednesday,
March 10th at 10:55 a.m. Eastern Time
For presentations that are webcast live, an access link will be
available on the Sangamo Therapeutics website in the Investors and
Media section under Events and Presentations. The presentations
will also be available on the Sangamo Therapeutics website after
the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, cell therapy, and genome
engineering. For more information about Sangamo, visit
www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210218005058/en/
Investor Relations & Media
Inquiries Aron Feingold 628.252.7494
afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Apr 2024 to May 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From May 2023 to May 2024